Author: Justine Alford

Our top stories this week include the NHS’ commitments to early diagnosis, a budget boost for research, and trials for new experimental treatments.

Will personalised medicine become the norm of cancer treatment? In this Science Surgery instalment, we asked experts for their thoughts on this question.

Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier.

In our round-up of this year’s NCRI conference we reveal exciting new research that’s helping scientists get to know cancer better.

Different types of brain tumours may share similar survival strategies, opening up new treatment research avenues.

Obesity and sugar hogged the headlines this week alongside success stories for personalised medicine. Read the digest for more.

This week’s news featured worrying obesity and cancer trends in the US and a call for more robust evidence to back up cancer drugs’ effectiveness. Read the digest for more.

This year’s Nobel Prize in Chemistry was awarded to the developers of cool microscopes. And the tech is boosting cancer research.

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

Answering this question isn’t a simple case of ‘yes’ or ‘no’. It depends on the way that the term ‘cancer’ is defined.